BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  SIFI provides updates on the UK and US regulatory pathways for AKANTIOR® in the treatment of acanthamoeba keratitis

  December 16, 2024

   · 

  3 min read
• Press Releases

  AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card

  December 16, 2024

   · 

  5 min read
• Press Releases

  Corcept’s Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with Hypercortisolism

  December 16, 2024

   · 

  5 min read
• Press Releases

  HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial

  December 16, 2024

   · 

  4 min read
• Press Releases

  Whole Exome Sequencing Market to Reach USD 4.72 Billion by 2031

  December 16, 2024

   · 

  1 min read
• Press Releases

  Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

  December 16, 2024

   · 

  11 min read
• Press Releases

  De-identified Health Data Market Rising Valuation to Reach USD 13.80 Billion by 2031

  December 16, 2024

   · 

  1 min read
• Press Releases

  Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

  December 16, 2024

   · 

  6 min read
• Press Releases

  Naropa University Announces Separation of Center For Psychedelic Studies

  December 16, 2024

   · 

  4 min read
• Press Releases

  Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

  December 16, 2024

   · 

  9 min read